CDK5: a protein kinase of the CDK family. Unlike other members of this family, it is not activated by cyclins but by p35 (CDK5R1) and p39. An important regulator of neuronal positioning during brain development. May also play a role in synaptogenesis and neurotransmission. Substrates include TAU, MAP2, NF-H and -M, Nudel, PDE6, beta-catenin, amphyphysin, dynamin I, synapsin 1, Munc-18, and NMDA receptor 2A. Plays a role in myogenesis, haematopoietic cell differentiation, spermatogenesis, insulin secretion, and lens differentiation. Implicated in the pathology of neurofibrillary tangles and formation of senile plaques, hallmarks of Alzheimer?s disease. Induces tau phosphorylation and aggregation and neurofibrillary tangle deposition and neurodegeneration in in vitro and in vivo animal models. Brain samples from Alzeimer?s pateints show elevated CDK5 activity.
Protein type: Kinase, protein; EC 2.7.11.1; Cell cycle regulation; Protein kinase, CMGC; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK5 subfamily; CDK5 subfamily
Chromosomal Location of Human Ortholog: 7q36
Cellular Component: cyclin-dependent protein kinase 5 activator complex; postsynaptic density; dendrite; perikaryon; cytosol; postsynaptic membrane; growth cone; cytoskeleton; membrane; cell soma; lamellipodium; axon; cytoplasm; nucleus; cell junction; neuromuscular junction; filopodium
Molecular Function: acetylcholine receptor activator activity; ErbB-2 class receptor binding; protein serine/threonine kinase activity; protein binding; ErbB-3 class receptor binding; ephrin receptor binding; cyclin-dependent protein kinase activity; p53 binding; cytoskeletal protein binding; tau-protein kinase activity; kinase activity; ATP binding; protein kinase activity
Biological Process: Schwann cell development; negative regulation of synaptic plasticity; axon extension; cerebellar cortex formation; rhythmic process; regulation of synaptic plasticity; motor axon guidance; sensory perception of pain; regulation of cell migration; receptor clustering; neuron differentiation; corpus callosum development; regulation of apoptosis; receptor catabolic process; oligodendrocyte differentiation; neurite development; central nervous system neuron development; synaptic transmission, glutamatergic; skeletal muscle development; dendrite morphogenesis; cell division; synaptic vesicle endocytosis; negative regulation of protein ubiquitination; negative regulation of transcription, DNA-dependent; synaptic transmission, dopaminergic; axon guidance; regulated secretory pathway; negative regulation of protein export from nucleus; positive regulation of protein binding; protein amino acid autophosphorylation; cell-matrix adhesion; neuron migration; nucleocytoplasmic transport; negative regulation of axon extension; negative regulation of cell cycle; synaptic transmission; intracellular protein transport; synaptogenesis; behavioral response to cocaine; positive regulation of neuron apoptosis; visual learning; cortical actin cytoskeleton organization and biogenesis; layer formation in the cerebral cortex; serine phosphorylation of STAT3 protein; negative regulation of proteolysis; hippocampus development; peptidyl-threonine phosphorylation; cell cycle; positive regulation of calcium ion-dependent exocytosis; cell proliferation; embryonic development; neuron apoptosis; peptidyl-serine phosphorylation; synaptic vesicle exocytosis; positive regulation of protein kinase activity; blood coagulation; regulation of excitatory postsynaptic membrane potential; phosphorylation
Disease: Lissencephaly 7 With Cerebellar Hypoplasia
Show more